ArticlePloS one2022

A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis.

Rieko Bessho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.